BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11071355)

  • 1. Fluorescence in situ hybridization: uses and limitations.
    Gozzetti A; Le Beau MM
    Semin Hematol; 2000 Oct; 37(4):320-33. PubMed ID: 11071355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in situ hybridization: molecular probes for diagnosis of pediatric neoplastic diseases.
    Raimondi SC
    Cancer Invest; 2000; 18(2):135-47. PubMed ID: 10705876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
    Tansatit M
    Methods Mol Biol; 2017; 1541():75-90. PubMed ID: 27910016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: a multicenter prospective study of 2302 patients in China.
    Lai YY; Huang XJ; Li J; Zou P; Xu ZF; Sun H; Shao ZH; Zhou DB; Chen FP; Liu ZG; Zhu HL; Wu DP; Wang C; Zhang Y; Li Y; Hou M; Du X; Wang X; Li W; Lai YR; Zhou J; Zhou YH; Fang MY; Qiu L; Wang XM; Zhang GS; Jiang M; Liang YM; Zhang LS; Chen XQ; Bai H; Lin JY
    Leuk Res; 2015 May; 39(5):530-5. PubMed ID: 25823643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetics.
    Kearney L
    Best Pract Res Clin Haematol; 2001 Sep; 14(3):645-69. PubMed ID: 11640874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodologies in cancer cytogenetics and molecular cytogenetics.
    Wang N
    Am J Med Genet; 2002 Oct; 115(3):118-24. PubMed ID: 12407691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetics: an indispensable tool for cancer diagnosis.
    Wan TS; Ma ES
    Chang Gung Med J; 2012; 35(2):96-110. PubMed ID: 22537925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent in situ hybridization (FISH) in bone marrow and peripheral blood of leukemia patients: implications for occupational surveillance.
    McDevitt MA; Condon M; Stamberg J; Karp JE; McDiarmid M
    Mutat Res; 2007 Apr; 629(1):24-31. PubMed ID: 17276720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization for molecular cytogenetic analysis in filamentous fungi.
    Tsuchiya D; Taga M
    Methods Mol Biol; 2010; 638():235-57. PubMed ID: 20238274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?
    Costa D; Valera S; Carrió A; Arias A; Muñoz C; Rozman M; Belkaid M; Coutinho R; Nomdedeu B; Campo E
    Leuk Res; 2010 Nov; 34(11):1437-41. PubMed ID: 20226525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization techniques for cytogenetic and genomic analyses.
    Walling JG; Zhang W; Jiang J
    Methods Mol Biol; 2013; 956():13-27. PubMed ID: 23135841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cytogenetics of pituitary adenomas, assessed by FISH technique.
    Kontogeorgos G
    Front Horm Res; 2004; 32():205-16. PubMed ID: 15281348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Common Abnormalities Seen in Chronic Lymphocytic Leukemia Using Fluorescence In Situ Hybridization.
    Meyer RG; Van Dyke DL
    Methods Mol Biol; 2019; 1881():35-49. PubMed ID: 30350196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interphase fluorescence in situ hybridization analysis detects a much higher rate of thyroid tumors with clonal cytogenetic deviations of the main cytogenetic subgroups than conventional cytogenetics.
    Drieschner N; Rippe V; Laabs A; Dittberner L; Nimzyk R; Junker K; Rommel B; Kiefer Y; Belge G; Bullerdiek J; Sendt W
    Cancer Genet; 2011 Jul; 204(7):366-74. PubMed ID: 21872823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of fluorescence in situ hybridization techniques for molecular cytogenetics.
    Raap AK
    Curr Protoc Cytom; 2001 May; Chapter 8():Unit 8.1. PubMed ID: 18770737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cytogenetic applications in analysis of the cancer genome.
    Rao PH; Nandula SV; Murty VV
    Methods Mol Biol; 2007; 383():165-85. PubMed ID: 18217685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.
    Dong H; Yang HS; Jagannath S; Stephenson CF; Brenholz P; Mazumder A; Chari A
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):366-74. PubMed ID: 22658896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of tumorcytogenetics in tumor diagnostics].
    Wenzel F; Röthlisberger B
    Ther Umsch; 2008 Sep; 65(9):473-80. PubMed ID: 18791960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cytogenetic analysis in the study of brain tumors: findings and applications.
    Bayani J; Pandita A; Squire JA
    Neurosurg Focus; 2005 Nov; 19(5):E1. PubMed ID: 16398459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Strategies to identify supernumerary chromosomal markers in constitutional cytogenetics].
    Douet-Guilbert N; Basinko A; Le Bris MJ; Herry A; Morel F; De Braekeleer M
    Pathol Biol (Paris); 2008 Sep; 56(6):362-7. PubMed ID: 18456432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.